MRM on Nasdaq

Medirom Healthcare Technologies Inc.

Personal services company, listed on Nasdaq (MRM)1

In its 2025 annual report (Form 20-F) the company says: “We are a joint-stock corporation incorporated in Japan under the Companies Act. Our Company has developed our business both through organic development of our branded relaxation salons (primarily Re.Ra.Ku salons) and through acquisitions.”4

Price unavailable

Last updated Oct 20, 2026.

Overview

8.3BRevenue, fiscal 20242
148.8MNet income, fiscal 20242

Compare with another stock.

  • TickerMRM on Nasdaq1
  • IndustryServices-Personal Services1
  • HeadquartersM01
  • Incorporated inJapan3
  • Business address2-3-1 Daiba, Minato-Ku, Tokyo3
  • Filer categoryNon-accelerated filer, Emerging growth company3

See how the biggest companies compare on our leaderboards

Our Company was originally incorporated in Japan on July 13, 2000 under the name “Kabushiki Kaisha Young Leaves.” In November 2001, we changed our name to “ReRaKu Inc.” and in January 2017, we changed our name to “MEDIROM Inc.” In March 2020, our Company’s English name was changed to “MEDIROM Healthcare Technologies Inc.” In December 2020, the Company listed its ADSs representing its common shares on The Nasdaq Capital Market. We are a joint-stock corporation incorporated in Japan under the Companies Act.4 From its latest annual report

Financials

From the company’s reports to the SEC. Every number links to the filing it came from. Figures are in JPY, the currency the company reports in.

Key numbers, fiscal 2024

27.1%Gross margin2
-0.2%Operating margin2
1.8%Net margin2
21.5%Revenue growth, 20242
15.9%Return on equity2
0.82×Debt to equity2
-1.4B JPYFree cash flow2

Where the money goes

Where each dollar of revenue went, fiscal 2024

  • Cost of revenue71¢6.1B JPY
  • Selling, general and admin26¢2.2B JPY
  • Income tax1¢90.5M JPY
  • Profit2¢148.8M JPY

Out of 8.3B JPY in revenue.2

Financial statements

Revenue56728.3B JPY in 2024+112% since 2019
02.5B JPY5.0B JPY7.5B JPY10.0B JPY2019: 3.9B JPY3.9B JPY20192020: 3.3B JPY3.3B JPY2020−14%2021: 5.4B JPY5.4B JPY2021+62%2022: 7.0B JPY7.0B JPY2022+29%2023: 6.8B JPY6.8B JPY2023−2%2024: 8.3B JPY8.3B JPY2024+22%
Gross profit22.2B JPY in 2024+18% since 2022
01.0B JPY2.0B JPY3.0B JPY2022: 1.9B JPY1.9B JPY20222023: 1.6B JPY1.6B JPY2023−18%2024: 2.2B JPY2.2B JPY2024+43%
Operating income5672-18.1M JPY in 2024
-750.0M JPY-500.0M JPY-250.0M JPY0250.0M JPY2019: 34.4M JPY34.4M JPY20192020: -746.1M JPY-746.1M JPY20202021: -470.6M JPY-470.6M JPY2021−37%2022: 97.0M JPY97.0M JPY20222023: -391.6M JPY-391.6M JPY20232024: -18.1M JPY-18.1M JPY2024−95%
Net income5672148.8M JPY in 2024+758% since 2019
-1.0B JPY-500.0M JPY0500.0M JPY2019: 17.3M JPY17.3M JPY20192020: -539.2M JPY-539.2M JPY20202021: -990.7M JPY-990.7M JPY2021+84%2022: 149.0M JPY149.0M JPY20222023: 115.4M JPY115.4M JPY2023−23%2024: 148.8M JPY148.8M JPY2024+29%
Fiscal year2018201920202021202220232024
Revenue3.9B JPY53.3B JPY65.4B JPY77.0B JPY26.8B JPY28.3B JPY2
Cost of revenue5.1B JPY25.3B JPY26.1B JPY2
Gross profit1.9B JPY21.6B JPY22.2B JPY2
Selling, general and admin871.9M JPY51.1B JPY61.8B JPY71.8B JPY22.0B JPY22.2B JPY2
Operating expenses5.9B JPY76.9B JPY27.2B JPY28.3B JPY2
Operating income34.4M JPY5-746.1M JPY6-470.6M JPY797.0M JPY2-391.6M JPY2-18.1M JPY2
Interest13.6M JPY513.2M JPY611.9M JPY79.8M JPY736.9M JPY7
Income before tax-414.5M JPY7179.8M JPY220.6M JPY247.7M JPY2
Income tax16.0M JPY5-87.5M JPY6576.2M JPY730.8M JPY2-94.4M JPY2-90.5M JPY2
Net income17.3M JPY5-539.2M JPY6-990.7M JPY7149.0M JPY2115.4M JPY2148.8M JPY2
Earnings per share5 JPY/shares5-134 JPY/shares6-203 JPY/shares731 JPY/shares224 JPY/shares229 JPY/shares2
Earnings per share (diluted)4 JPY/shares5-134 JPY/shares6-203 JPY/shares727 JPY/shares222 JPY/shares229 JPY/shares2
Shares (weighted, basic)4.9M shares74.9M shares24.9M shares25.1M shares2
Shares (weighted, diluted)4.9M shares75.5M shares25.2M shares25.9M shares2

Compare Medirom Healthcare Technologies Inc. with another company

Corporate structure

Medirom Healthcare Technologies Inc. sits at the top of its group. 1 entity on record. Switch between the flow chart and the network, and select any entity to see its details.

Major holders of Medirom Healthcare Technologies Inc.

  • Kouji Eguchi Filed SCHEDULE 13D/A on Medirom Healthcare Technologies Inc., latest Aug 28, 2026 (3 filings since Jan 25, 2023)
  • Kufu Co Holdings Inc. Filed SCHEDULE 13D/A on Medirom Healthcare Technologies Inc., latest Jul 17, 2026 (4 filings since Jan 6, 2023)
  • Triple One Investment Partnership Filed SC 13G on Medirom Healthcare Technologies Inc., latest Dec 10, 2024
  • Medirom Healthcare Technologies Inc. M0

Built from major holders from Schedules 13D and 13G. Each entity in the chart links to its source.

What it owns

What Medirom Healthcare Technologies Inc. reports owning in its annual reports to the SEC: buildings, land and equipment, real estate and locations, investments, intangible assets and inventory, at the end of its latest fiscal year and a year before.

Property and equipment

ItemLatestA year beforeChange
Property and equipment, before depreciation796.0M JPY2 Dec 31, 2024747.9M JPY2 Dec 31, 2023+6.4%
Accumulated depreciation360.4M JPY2 Dec 31, 2024296.4M JPY2 Dec 31, 2023+21.6%
Property and equipment, net435.7M JPY2 Dec 31, 2024451.5M JPY2 Dec 31, 2023−3.5%
Operating-lease assets (leased space)2.1B JPY2 Dec 31, 20242.1B JPY2 Dec 31, 2023−0.7%

Real estate and locations

ItemLatestA year beforeChange
Stores3082 Dec 31, 20243142 Dec 31, 2023−1.9%

Investments

ItemLatestA year beforeChange
Cash and cash equivalents$2.1M2 Dec 31, 2024$755.0K7 Dec 31, 2023+177.2%
Marketable securities, current6.2M JPY2 Dec 31, 202426.5M JPY2 Dec 31, 2023−76.8%
Long-term investments87.4M JPY2 Dec 31, 202481.5M JPY2 Dec 31, 2023+7.2%

Intangibles and goodwill

ItemLatestA year beforeChange
Goodwill389.1M JPY2 Dec 31, 2024484.6M JPY2 Dec 31, 2023−19.7%
Intangible assets, net (excluding goodwill)1.1B JPY2 Dec 31, 2024920.7M JPY2 Dec 31, 2023+23.7%
Indefinite-lived intangibles (excluding goodwill)369.0K JPY2 Dec 31, 2024369.0K JPY2 Dec 31, 20230%
Finite-lived intangibles, gross1.5B JPY2 Dec 31, 20241.2B JPY2 Dec 31, 2023+26.2%
Accumulated amortization373.8M JPY2 Dec 31, 2024277.9M JPY2 Dec 31, 2023+34.5%
Finite-lived intangibles, net1.1B JPY2 Dec 31, 2024920.3M JPY2 Dec 31, 2023+23.8%

Inventory

ItemLatestA year beforeChange
Inventory, total151.6M JPY2 Dec 31, 2024140.0M JPY2 Dec 31, 2023+8.3%

Leadership

Who has led Medirom Healthcare Technologies Inc., and when. Pick a name to see everywhere that person has worked.

Chief executive

  1. Kouji Eguchi2026–now

Chief financial officer

  1. Fumitoshi Fujiwara2026–now
Board members and other officers (5)

Timeline

  1. Mar 18, 2026New chief executive Kouji Eguchi becomes CEO9

Filings

176 filings to the SEC since October 2021: 4 annual reports, 6 insider forms, 8 large holders, 158 other. The latest 20:

  1. Oct 13, 20266-K EDGAR
  2. Aug 28, 2026SCHEDULE 13D/A EDGAR
  3. Aug 28, 20264 EDGAR
  4. Aug 27, 20266-K EDGAR
  5. Aug 27, 20266-K EDGAR
  6. Aug 7, 20266-K EDGAR
  7. Aug 7, 20266-K EDGAR
  8. Jul 17, 2026SCHEDULE 13D/A EDGAR
  9. Jun 25, 20266-K EDGAR
  10. Jun 9, 20263 EDGAR
  11. May 29, 20266-K EDGAR
  12. May 28, 20266-K EDGAR
  13. Apr 30, 2026NT 20-F EDGAR
  14. Apr 22, 20266-K EDGAR
  15. Apr 9, 20266-K EDGAR
  16. Mar 30, 2026SCHEDULE 13D/A EDGAR
  17. Mar 18, 20263 OWNERSHIP DOCUMENT EDGAR
  18. Mar 18, 20263 OWNERSHIP DOCUMENT EDGAR
  19. Mar 18, 20263 OWNERSHIP DOCUMENT EDGAR
  20. Mar 18, 20263 OWNERSHIP DOCUMENT EDGAR

The 176 filings since October 2021 can be filtered by form type and year here when JavaScript is on.

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

Major holders

Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.

Held by these funds

The largest holders among investment managers' 13F reports for the quarter ending Jun 30, 2026. Change is in shares since the quarter before.

FundSharesValueShare of the fundChange
Citadel Advisors LLC56,102$57.8K0.0%New
UBS Group AG27,181$28.0K0.0%+633
Two Sigma Securities, LLC10,565$10.9K0.0%−3,412
GAMMA Investing LLC3,798$3.9K0.0%−2,611
Rhumbline Advisers3,104$3.2K0.0%+1,120
Arax Advisory Partners300$3090.0%New
Hrt Financial LP54,755$560.0%+42,850
Virtu Financial LLC15,785$160.0%New

13F reports cover disclosed long positions in U.S. stocks only.

SEC filer profile

How Medirom Healthcare Technologies Inc. is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.

  • Name on EDGARMedirom Healthcare Technologies Inc.1
  • CIK0001819704
  • Filer statusNon-accelerated filer an emerging growth company; not a shell company4
  • Incorporated inJapan4
  • Fiscal year endsDecember 311
  • Industry code (SIC)7200 Services-Personal Services1
  • SEC reviewing officeOffice of Trade & Services, Division of Corporation Finance1
  • Business address2-3-1 Daiba, Minato-Ku, Tokyo, Japan1
  • Phone81-3-6721-73641
  • Shares outstanding7,901,950 shares as of Dec 31, 20244
  • AuditorGuzmanGray, Costa Mesa, California PCAOB ID 7143; no auditor attestation of internal control over financial reporting4
  • On EDGAR sinceSep 11, 20201
  • Filings222 in all: 6-K (150), CORRESP (9), F-1/A (8), UPLOAD (6), 20-F (5), 3 (5), NT 20-F (5), SCHEDULE 13D/A (5)1
    All 26 form types

    SEC STAFF LETTER (4), EFFECT (3), F-1 (3), 6-K/A (2), DRS (2), SC 13D (2), SC 13G (2), 4 (1), 424B4 (1), 424B5 (1), 8-A12B (1), CERT (1), DRS/A (1), DRSLTR (1), F-1MEF (1), F-3 (1), RW (1), S-8 (1)

  • Latest filingsAnnual report (20-F) Apr 29, 2025

Securities registered for trading

ClassSymbolExchange
American Depositary Shares, each representing one common shareMRMThe Nasdaq Stock Market LLC
Common Shares, no par value*The Nasdaq Stock Market LLC

From the cover page of the 20-F filed Apr 29, 2025 (Section 12(b) of the Exchange Act).4

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16